Celsion (CLSN) Adds Christine A. Pellizzari to Board

Go back to Celsion (CLSN) Adds Christine A. Pellizzari to Board

Celsion (CLSN) Appoints Stacy R. Lindborg, Ph.D. to Board

June 8, 2021 8:10 AM EDT

Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, today announced the appointment of Stacy R. Lindborg, Ph.D. to its Board of Directors, effective June 4, 2021. Dr. Lindborgs appointment fills the... More